Shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) have earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $99.50.
USPH has been the topic of a number of research analyst reports. Barrington Research raised their target price on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. Citizens Jmp reiterated a “market outperform” rating and set a $98.00 price objective on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. Finally, Citigroup reaffirmed an “outperform” rating on shares of U.S. Physical Therapy in a report on Monday.
View Our Latest Analysis on U.S. Physical Therapy
Insider Activity at U.S. Physical Therapy
Hedge Funds Weigh In On U.S. Physical Therapy
Several large investors have recently modified their holdings of the business. Hantz Financial Services Inc. increased its holdings in shares of U.S. Physical Therapy by 56.4% in the 4th quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock worth $29,000 after buying an additional 132 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of U.S. Physical Therapy during the second quarter valued at approximately $30,000. Advisory Services Network LLC bought a new stake in U.S. Physical Therapy in the 3rd quarter worth approximately $39,000. iSAM Funds UK Ltd bought a new stake in U.S. Physical Therapy during the third quarter valued at about $52,000. Finally, Parallel Advisors LLC lifted its holdings in shares of U.S. Physical Therapy by 75.2% in the first quarter. Parallel Advisors LLC now owns 785 shares of the company’s stock worth $59,000 after buying an additional 337 shares in the last quarter.
U.S. Physical Therapy Stock Performance
NYSE:USPH opened at $80.98 on Monday. U.S. Physical Therapy has a twelve month low of $58.19 and a twelve month high of $93.50. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of 476.40, a price-to-earnings-growth ratio of 2.27 and a beta of 1.13. The company has a current ratio of 1.27, a quick ratio of 1.19 and a debt-to-equity ratio of 0.48. The company has a 50-day moving average of $72.10 and a 200-day moving average of $74.08.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.06). The firm had revenue of $214.06 million during the quarter, compared to analysts’ expectations of $211.36 million. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%. The firm’s revenue was up 8.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.81 EPS. Analysts forecast that U.S. Physical Therapy will post 2.96 earnings per share for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 21st will be paid a dividend of $0.46 per share. The ex-dividend date of this dividend is Friday, August 21st. This represents a $1.84 annualized dividend and a dividend yield of 2.3%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 1,082.35%.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Recommended Stories
- Five stocks we like better than U.S. Physical Therapy
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
